This superior efficacy is attributed to IF's ability to activate MIF signaling, which in turn promotes AMPK-mediated autophagy and reverses HFD-induced apoptosis in the livers of NAFLD mice. Here, MIF is linked to metabolic dysfunction-associated steatotic liver disease.